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Background: Endometrial polyps (EP) and endometriosis are both estrogen-dependent overgrowths of the
endometrium. Several studies have shown a higher frequency of EP in endometriosis patients when compared with
women without endometriosis. Therefore, we performed a meta-analysis to investigate the risk of EP in women
with endometriosis.
Methods: This meta-analysis searched for articles published between 1964 and 2014 in PubMed, Embase, and
Cochrane Library, as well as in Chinese databases, including CNKI, VIP and Wanfang, regarding the association
between endometriosis and EP. Nine cohort studies and one case–control study including 2896 women were
included in this meta-analysis. The EP risk was evaluated using relative risk (RR) with a 95 % confidence interval (CI).
Heterogeneity, small study effect and publication bias were assessed using Higgins I2, sensitivity analysis and funnel
plots, respectively.
Results: The risk of EP increased in women with endometriosis compared with those without endometriosis (the
pooled RR, 2.81; 95 % CI, 2.48–3.18). No significant heterogeneity, small study effect or publication bias was found.
The risk of EP slightly increased in women with endometriosis at stages 2–4 compared with those at stage 1
(Pooled effect size: stage 2 versus stage 1, RR, 1.22, 95 % CI, 1.04 - 1.42; stage 3 versus stage 1, RR, 1.23, 95 % CI,
1.06–1.42; stage 4 versus stage 1, RR, 1.29, 95 % CI, 1.11–1.51; stages 2–4 versus stage 1, RR, 1.24, 95 % CI, 1.10–1.40);
however, no significantly different risk of EP in women with endometriosis existed between the other stages.
Conclusion: The results suggest that it is important to identify whether patients with endometriosis also have EP
and then remove any coexisting EP via hysteroscopy, especially for infertile patients. This process will be clinically
helpful to treat endometriosis-related infertility in patients with endometriosis, especially for those with
endometriosis that is more serious than stage 1.
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Endometriosis is characterized by the presence of endo-
metrial glands and stroma at extrauterine locations and
affects approximately 10 % of women of reproductive age,
resulting in dysmenorrhea, infertility and decreased
quality of life [1, 2]. Although its exact pathogenesis is
unclear, endometriosis is considered to be an estrogen-
dependent disease [3]. The expression patterns of estrogen
receptors (ER) and aromatase are both altered in patients* Correspondence: peishuliu@126.com
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ism in the endometrium of patients with endometriosis is
quite different from that in normal endometrium [3].
Endometrial polyps (EP), the localized hyperplastic
growth of endometrial glands and stroma, can affect up to
25 % of women, especially infertile women [7]. Similar to
endometriosis, EP is also believed to be an estrogen-
dependent disease [8]. The concentrations of ER and
progesterone receptors (PR) were found to be significantly
higher in the endometrium from women with EP than in
normal endometrium [9, 10]. Moreover, the aromatase
level was remarkably higher in the endometrium from EP
patients than in control endometrium [11]. Recent
evidence showed that EP was a potential cause forle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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increased the pregnancy rate [12].
Because of their common pathogenesis, endometriosis
and EP may be associated with each other in some
aspects. Emerging evidence suggests a higher frequency
of EP in endometriosis patients compared with women
without endometriosis [12–15]; however, whether endo-
metriosis patients have a high risk of EP has not been
demonstrated. The present article evaluated the associ-
ation of endometriosis and EP. To investigate whether
endometriosis patients have a high risk of EP, we
performed a meta-analysis using previously published
studies.Methods
Search strategy and selection criteria
For the meta-analysis, we systematically and carefully
searched PubMed, Embase, Cochrane Library, as well as
Chinese databases, including CNKI (China National
Knowledge Infrastructure), VIP (Chinese Scientific Jour-
nals Database) and Wanfang for relevant studies avail-
able online and published between 1964 and 2014. The
search terms “endometriosis and endometrial polyps” or
“endometriosis and uterine polyps” or “endometriosis
and endometrial neoplasm” were used as key words. The
searches were conducted independently by two authors
(QM Zheng and YJ Zhao).
The included studies had to meet the following
criteria: 1) endometriosis and EP diagnosed by surgery
or pathology, 2) clearly described selection of controls,
3) human study, and 4) cohort or case–control study.
Articles were excluded if they met the following criteria:
1) case report or review article, 2) animal or cell experi-
ment, or 3) not published in English or Chinese.Fig. 1 A flowchart depicting the selection of studies for
the meta-analysisSelection of articles and data extraction
Two authors (QM Zheng and YJ Zhao) independently
scanned the titles and abstracts and evaluated the potential
eligibility of all of the studies according to the inclusion and
exclusion criteria. Any disagreement in the process was
resolved by discussion or the third author (J Zhao). The
references of the selected articles were also checked for
possible studies to include. Data extraction was also per-
formed by the two authors using a standardized data-
collection form. The following data were extracted from
the eligible studies: the first author, year of publication,
study population, study design, numbers of women with
and without endometriosis, age, diagnosis of endometriosis
and EP, numbers of patients with EP in women with and
without endometriosis, numbers of endometriosis patients
at r-AFS (revised-American Fertility Society) or AFS
(American Fertility Society) stages 1–4, and numbers ofwomen with EP at each stage of endometriosis. For articles
lacking the relevant data, an E-mail was sent to the authors
to request the information.Quality assessment
The quality of each study was independently assessed by
the two authors using the Newcastle-Ottawa Scale (NOS),
a validated tool for assessing the quality of non-randomized
studies in meta-analyses [16]. The NOS uses a star system
based on three aspects: selection of the study groups (up to
four points), comparability of the groups (up to two points),
and exposure or outcome (up to three points) for case–
control or cohort studies. We included studies with an
NOS score ≥ 5 in the current systematic review and meta-
analysis.Statistical analysis
We primarily assessed the risk of EP in women with
endometriosis compared with those without endometri-
osis. Further analysis was conducted to evaluate the risk
of EP in women with endometriosis according to the
stage of endometriosis. The meta-analysis was per-
formed with STATA software (version 12.0 StataCorp,
College Station, TX). All of the results for the binary
outcomes are shown as the relative risk (RR) with a
95 % confidence interval (CI) in the case–control or co-
hort studies. The impact of heterogeneity was assessed
using Higgins I2 [17]. When P > 0.1 or I2 ≤ 50 %, the
fixed effect model using the Mantel-Haensze
l method was used because it indicated acceptable het-
erogeneity. Conversely, the random effects model was
used when P <0.1 or I2 > 50 %.
Table 1 Summary of included studies
Author, year, place Study population Study design Cases Controls rameter measured Result
McBean, 1996, USA Women who had a
HSG, hysteroscopy,
and laparoscopy




88 women with hysterosalpingograms




Cases: 27; controls: 19
Mi Ran Kim, 2003, Korea Infertile women
undergoing
laparoscopy
Cohort 92 (mean age,
30.6 ± 3.9 years) had
laparoscopy-proved
endometriosis
91 (mean age, 30.8 ± 4.6 years) had
laparoscopy-proved absence of
endometriosis
mber (%) of patients
th endometrial polyps
Cases: 43 (46.7 %);
controls: 15 (16.5 %)




Cohort 94 (mean age,
30.6 ± 4.07 years)
had laparoscopy-proved
endometriosis
98 (mean age, 30.8 ± 3.4 years) had
laparoscopy-proved chronic pelvic
inflammation; 116 (mean age,
30.7 ± 2.61 years) had laparoscopy-proved
normal pelvic
mber (%) of patients
th endometrial polyps
Cases: 20 (21.3 %); chronic
pelvic inflammation: 4
(4.1 %); normal pelvic:
4 (3.4 %)
Jae Sun Park, 2009, Korea Infertile women
undergoing
laparoscopy
Cohort 434 (mean age,
31.38 ± 4.37 years)
had laparoscopy-proved
endometriosis
197 (mean age, 31.05 ± 5.48 years)
had laparoscopy-proved the absence
of endometriosis
mber (%) of patients
th endometrial polyps
Cases: 274 (63.0 %);
controls: 58 (29.8 %)





Cohort 158 (mean age,
31.0 ± 4.2 years) had
laparoscopy-proved
endometriosis
273 (mean age, 30.7 ± 5.3 years)
had no endometriotic foci found
during laparoscopy
mber (%) of patients
th endometrial polyps
Cases: 108 (68.35 %);
controls: 56 (20.51 %)




Cohort 84 (mean age,
30.87 ± 4.5 years) had
laparoscopy-proved
endometriosis
160 (mean age, 30.87 ± 4.5 years)
had laparoscopy-proved the absence
of endometriosis
mber (%) of patients
th endometrial polyps
Cases: 16 (19.0 %);
controls: 12 (7.5 %)
Hong Jin, 2013, China Women undergoing
surgery or physical
examination
Cohort 150 aged 23–53 (mean
age, 41.8 years) had
surgery and pathology
proved endometriosis
158 aged 23–53 (mean age,
39.11 years) had ultrasound proved
the absence of endometriosis
mber (%) of patients
th endometrial polyps
Cases: 23 (15.33 %);
controls: 10 (6.33 %)




Cohort 42 (mean age,
28.5 ± 2.5 years) had
laparoscopy-proved
endometriosis
78 (mean age, 28.5 ± 2.5 years)
had laparoscopy-proved the absence
of endometriosis
mber (%) of patients
th endometrial polyps
Cases: 8 (19.0 %);
controls: 4 (5.1 %)




Cohort 81 (mean age,
29.5 ± 4.71 years) had
laparoscopy-proved
endometriosis
110 (mean age, 29.5 ± 4.71 years)
had laparoscopy-proved the absence
of endometriosis
mber (%) of patients
th endometrial polyps
Cases: 17 (21 %);
controls: 8
(7.3 %)




Cohort 119 (mean age, 31.1 ± 3.0
years) had laparoscopy-proved
endometriosis
241 (mean age, 30.7 ± 4.1 years)
had laparoscopy-proved the absence
of endometriosis
mber (%) of patients
th endometrial polyps
Cases: 77 (64.7 %);
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analysis was performed by recalculating the pooled RR
after deleting the studies one at a time. To identify the
presence of publication bias, a funnel plot was produced
using the logRR of each study on the X-axis and the
standard error of the logRR of each study on the Y-axis.
Furthermore, the Harbord test was used to test the
symmetry of the funnel plot. P > 0.5 suggested that the
funnel plot was symmetric and that no significant publi-
cation bias existed.
Results
Included studies and quality assessment
As shown in Fig. 1, we collected 418 articles from the
databases. After deleting the duplicates and screening
titles and abstracts, 20 articles remained for eligibility
assessment. Of the 20 studies selected after searching the
database, only 11 studies were found to meet the inclusion
criteria. The 11 studies, including 10 cohort studies and 1
case–control study, were published between 1996 and
2014. Of the 11 studies, one was excluded for its NOS
score < 5. Therefore, 9 cohort studies [12, 13, 15, 18–23]
and 1 case–control study [24] including 1286 women with
endometriosis and 1610 women without endometriosis
were included in the meta-analysis (Table 1). The studies
were conducted in the United States (n = 1), Korea (n = 2),
and China (n = 7). The NOS scores of the 10 included
studies ranged from 5 to 7 (Additional file 1: Table S1),Fig. 2 Forest plot of the 10 included studies evaluating the association betand the mean score was 6.1 (± SEM 0.2769). Of the 10
studies, only 5 studies analyzed the association of EP in
women with endometriosis according to AFS or r-AFS
stages. The NOS scores of the 5 studies ranged from 6 to
7 (Additional file 2: Table S2), and the mean score was 6.8
(± SEM 0.20).
Outcomes
The fixed effect model with the Mantel-Haenszel
method was used because no obvious heterogeneity was
found (P = 0.146, I2 = 32.8 %, Fig. 2). As depicted in
Fig. 2, the pooled RR of 2.81 (95 % CI, 2.48–3.18)
revealed that the risk of EP increased in women with
endometriosis (47.67 %) compared with those without
endometriosis (14.97 %). Then, we analyzed the risk of
EP in women with different stages of endometriosis. For
the articles reporting the association of EP in women with
endometriosis according to AFS or r-AFS stages, the
results of the heterogeneity tests were P >0.1, I2 = 0 %
(Figs. 3 and 4, Additional file 3: Figure S1 and Additional
file 4: Figure S2). Therefore, the fixed effect model with
the Mantel-Haenszel method was used to calculate the
pooled RR. As shown in Figs. 3 and 4, the risk of EP
slightly increased in women with endometriosis at stages
2–4 (61.46, 61.64 and 64.20 %) when compared with those
at stage 1 (51.38 %. Pooled effect size: stage 2 versus stage
1, RR, 1.22, 95 % CI, 1.04–1.42; stage 3 versus stage 1, RR,
1.23, 95 % CI, 1.06–1.42; stage 4 versus stage 1, RR, 1.29,ween endometriosis and EP
Fig. 3 Forest plots of the 5 studies evaluating the association between EP and endometriosis according to the endometriosis stage (stages 2 and
3 versus stage 1)
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95 % CI, 1.10–1.40). However, no significantly different
risk of EP in women with endometriosis existed between
the other stages (Additional file 3: Figure S1 and Additional
file 4: Figure S2).Publication bias and sensitivity analysis
As indicated in Fig. 5, the funnel plot was visually
symmetric. Then, the Harbord plot was used to test the
symmetry of the funnel plot. The funnel plot was consid-
ered symmetric because the regression line had a positive
slope through the origin of the coordinates (P = 0.973).
Therefore, no obvious publication bias existed in thecurrent meta-analysis. A sensitivity analysis was per-
formed to evaluate whether any small study effect influ-
enced the pooled effect size. No significant changes were
observed in the leave-one-out sensitivity analysis (Fig. 6).
Thus, the outcome of the current meta-analysis can be
considered to be stable.Discussion
In this meta-analysis of cohort and case–control studies
evaluating the association between EP and endometri-
osis, we found a significantly increased risk of EP in
women with endometriosis compared with those with-
out endometriosis. Moreover, the risk of EP in women
Fig. 4 Forest plots of the 5 studies evaluating the association between EP and endometriosis according to the endometriosis stage (stages 4 and
2–4 versus stage 1)
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pared with those at stage 1; however, no significant
difference was found for the risk of EP in women with
endometriosis at stage 2, stage 3 or stage 4. Therefore,
endometriosis patients have a significantly high risk of
EP, especially for endometriosis that is more serious than
stage 1.
The precise pathogenesis of endometriosis or EP is not
clear. The most widely accepted theory is that the two
diseases are both estrogen dependent [3, 8]. EP is the local-
ized hyperplastic growth of endometrial glands and stroma,
while endometriosis is the ectopic growth of endometrial
glands and stroma. Both diseases include the overgrowth ofthe endometrium, a process that requires the support of
estrogen. The expression patterns of ER and aromatase are
both altered in endometriosis and EP patients [4, 6, 9, 11].
As an enzyme, aromatase can catalyze the conversion of
androgen to estrogen, increasing the local concentration of
estrogen. Estrogen metabolism, including aromatase and
17β-hydroxysteroid dehydrogenase type 2 (17βHSD2, an
enzyme that inactivates estradiol to estrone), is altered in
the eutopic endometrium of women with endometriosis
compared with the eutopic endometrium of women with-
out endometriosis [3]. Additionally, increased proliferation
and decreased apoptosis have been observed in the eutopic
endometrium of women with endometriosis compared with
Fig. 5 a Funnel plot, using data from the 10 studies evaluating the association between endometriosis and EP, with the logRR of each study on
the X-axis and the standard error of the logRR on the Y-axis. b Harbord plot testing the symmetry of the funnel plot
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apoptosis, Bcl-2 was shown to be significantly increased in
the eutopic endometrium of women with endometriosis,
leading to the inhibition of apoptosis in the endometrium
[26]. Herein, the eutopic endometrium in women with
endometriosis was found to be different from that of
women without endometriosis. Increased proliferation,
decreased apoptosis and altered estrogen metabolism in the
endometrium of women with endometriosis facilitated the
presence of EP.
McBean first reported the association of endometriosis
and EP in 1996 [24]. Since then, several studies have
shown a higher frequency of EP in endometriosis patients
than in women without endometriosis [12–15]. In accord-
ance with previous studies, the present meta-analysisFig. 6 Sensitivity analysis of the meta-analysisconfirmed a significantly high risk of EP in women with
endometriosis. Furthermore, the risk of EP was increased
in endometriosis patients at stages 2–4 when compared
with those at stage 1. No significant heterogeneity, small
study effect or publication bias was found in the meta-
analysis.
Although endometriosis patients were statistically
shown to have a high risk of EP, this result should be
carefully comprehended for the following reasons. First,
only studies published in English and Chinese were in-
cluded in this meta-analysis, and thus, studies published
in other languages were omitted. Second, the pooled RR
of the current meta-analysis may not be accurate
because only a small number of studies were included.
Third, the risk of EP in the endometriosis patients
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ascertained because the included studies did not use
consistent staging criteria for endometriosis. Conse-
quently, this meta-analysis should be updated if studies
addressing the association of endometriosis and EP are
published in the future.Conclusion
The results suggest that it is important to determine
whether patients with endometriosis also have EP and then
remove any coexisting EP via hysteroscopy, especially for
infertile patients. This procedure will be clinically helpful to
treat endometriosis-related infertility in patients with endo-
metriosis, especially for those with endometriosis that is
more serious than stage 1.Additional files
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